WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 3801 Infant (under 12 months) mortality rate: 512
GDP / capita (US$): 8361 Child (under 5 years) mortality rate: 672

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 4'732  4'614  4'500  4'391  4'286  2'885  2'097  1'888 
Births 161  159  157  155  152  118  95  93 
Surviving infants 153  151  149  146  144  105  80  79 
Pop. less than 5 years 727  715  705  695  687  495  370  347 
Pop. less than 15 years 1'978  1'943  1'907  1'873  1'839  1'247  945  848 
Female 15-49 years 1'120  1'088  1'057  1'028  1'000  674  472  427 

Number of reported cases

(Click for retrospective incidence data for Liberia)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  960  789  1'060  34  5'977  6'567 
Mumps
ChartChart
 
Pertussis
ChartChart
  191  281  62 
Polio*
ChartChart
  98 
Rubella
ChartChart
  239 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  22  152  207 
Tetanus (total)**
ChartChart
  22  228  307 
Yellow fever
ChartChart
  137 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Liberia)
Vaccine year result method % card seen                                                
BCG 2012  94  DHS   58  87  97  74  73  87  45 
DTP1 2012  91  DHS   58  99  99  77  74  97 
DTP3 2012  71  DHS   58  99  92  65  63  89  48 
DTP4         
IPV1          29 
HepB_BD         
HepB3 2012  71  DHS   58  99  92  65  63  89 
Hib3 2012  71  DHS   58  99  92  65  63  89 
JapEnc         
MCV1          87  80  64  58  74  52 
MCV2         
MenA         
PCV1          99  99  72  90 
PCV2          91  88  61  58 
PCV3          98  91  56  45 
Pol3 2012  70  DHS   58  99  92  65  62  88  52 
Rota1          99  73 
RotaC          87  48 
RCV1         
TT2plus 1994  77  MICS     71  72  63  68  76  25 
PAB          71  72  63 
VAD1          21  28  49  25  58  26 
YFV 2012  73  DHS   58  84  73  56  54  73 
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Liberia)
BCG
ChartChart
  74  74  73  87  78 
DTP1
ChartChart
  77  77  74  97  80 
DTP3
ChartChart
  52  52  50  76  46 
HepB3
ChartChart
  52  52  50  76 
HepB_BD
ChartChart
 
Hib3
ChartChart
  52  52  50  76 
IPV1
 
MCV1
ChartChart
  64  64  58  74  63 
MCV2
ChartChart
 
PCV3
ChartChart
  56  56  45 
Pol3
ChartChart
  52  52  49  75  56 
RCV1
 
RotaC
ChartChart
 
YFV
ChartChart
  56  56  54  73 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 67
From 80 to 89% 20
From 50 to 79% 13
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 10 years (x2); No
IPV 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes
TT 14 years; +4 weeks; +6, +12 months; Yes pregnant women
VitaminA 6 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2020  2016-2020  2016-2020  2011-2015  2011-2015  2011-2015  2011-2015 
Nº of districts with microplans that include activities to raise immunization coverage number 15  15  15  15  15  15  15 

System performance

Total Nº districts in country number 15  15  15  15  15  15  15 
Nº districts with DTP3 coverage >=80% number 13  12  13  14 
% of districts with DTP3 coverage >=80% From 0 to 100% 87  80  20  13  87  93  53 
Nº districts with measles (MCV1) coverage >=95% number
% of districts with MCV1 coverage >=95% From 0 to 100% 20  20  13 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  No  No  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  No  No  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 15  14    28     

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.